Insider · CIK 0001236514
Michael Patrick Miller
Files at RIGL (RIGEL PHARMACEUTICALS INC), PBYI (PUMA BIOTECHNOLOGY, INC.), BTAIQ (BioXcel Therapeutics, Inc.). First filing Nov 13, 2025, latest Nov 13, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PBYI: PUMA BIOTECHNOLOGY, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | PBYIsell PUMA BIOTECHNOLOGY, INC. | $97k 20,000 shares | -27% | +114% from low-13% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 1, 2026 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Stock Option (right to buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Feb 3, 2026 |
| Jan 9, 2026 | BTAIQ BioXcel Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,000 | $0.00 | $0 | 17,000 | Jan 12, 2026 |
| Nov 11, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | SOpen-market sale Common Stock | -20,000 | $4.86 | $97k | 54,000 | Nov 13, 2025 |
| Jun 11, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 74,000 | Jun 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.